Can we manage prophylactic therapy in COVID-19 patients to prevent severe illness complications?

Many patients with COVID-19 have thromboembolic complications that worsen their prognosis. Herein, the authors propose a modified version of the CHA(2)DS(2)-VASc score, including 1 point for COVID-19, so that prophylaxis to protect against thromboembolic events would be indicated before the conditio...

Descripción completa

Detalles Bibliográficos
Autores principales: Reis, Paulo Eduardo Ocke, Lima, Marcos Cesar Braga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Angiologia e de Cirurgia Vascular (SBACV) 2020
Materias:
Innovations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202192/
https://www.ncbi.nlm.nih.gov/pubmed/34178079
http://dx.doi.org/10.1590/1677-5449.200057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202192/
https://www.ncbi.nlm.nih.gov/pubmed/34178079
http://dx.doi.org/10.1590/1677-5449.200057

Ejemplares similares